Kidney cancer clinical practice guidelines in oncology

Robert J. Motzer; Graeme B. Bolger; Barry Boston; Michael A. Carducci; Mayer Fishman; Steven L. Hancock; Ralph J. Hauke; Gary R. Hudes; Eric Jonasch; Philip Kantoff; Timothy M. Kuzel; Paul H. Lange; Ellis G. Levine; Chris Logothetis; Kim A. Margolin; Kamal Pohar; Bruce G. Redman; Cary N. Robertson; Wolfram E. Samlowski; Joel Sheinfeld

doi:10.6004/jnccn.2006.0089

Kidney cancer clinical practice guidelines in oncology

Robert J. Motzer, Graeme B. Bolger, Barry Boston, Michael A. Carducci, Mayer Fishman, Steven L. Hancock, Ralph J. Hauke, Gary R. Hudes, Eric Jonasch, Philip Kantoff, Timothy M. Kuzel, Paul H. Lange, Ellis G. Levine, Chris Logothetis, Kim A. Margolin, Kamal Pohar, Bruce G. Redman, Cary N. Robertson, Wolfram E. Samlowski, Joel Sheinfeld

Dermatology

Research output: Contribution to journal › Article › peer-review

8 Scopus citations

Abstract

An estimated 38,890 Americans will be diagnosed with kidney cancer and 12,840 will die of this disease in the United States in 2006. Renal cell carcinoma (RCC) constitutes approximately 2% of all malignancies, with a median age at diagnosis of 65 years. Smoking and obesity are among the risk factors for RCC development, and tumor grade, local extent of the tumor, presence of regional nodal metastases, and evidence of metastatic disease at presentation are the most important prognostic determinants of 5-year survival. These guidelines discuss evaluation, staging, treatment, and management after treatment.

Original language	English (US)
Pages (from-to)	1072-1081
Number of pages	10
Journal	JNCCN Journal of the National Comprehensive Cancer Network
Volume	4
Issue number	10
DOIs	https://doi.org/10.6004/jnccn.2006.0089
State	Published - Nov 2006

Keywords

Clear cell tumors
Kidney disease
NCCN Clinical Practice Guidelines
Nephrectomy
Renal cell carcinoma

ASJC Scopus subject areas

Oncology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.6004/jnccn.2006.0089

Cite this

Motzer, R. J., Bolger, G. B., Boston, B., Carducci, M. A., Fishman, M., Hancock, S. L., Hauke, R. J., Hudes, G. R., Jonasch, E., Kantoff, P., Kuzel, T. M., Lange, P. H., Levine, E. G., Logothetis, C., Margolin, K. A., Pohar, K., Redman, B. G., Robertson, C. N., Samlowski, W. E., & Sheinfeld, J. (2006). Kidney cancer clinical practice guidelines in oncology. JNCCN Journal of the National Comprehensive Cancer Network, 4(10), 1072-1081. https://doi.org/10.6004/jnccn.2006.0089

@article{9aea3da44a3c402fa4df57da180e21a2,

title = "Kidney cancer clinical practice guidelines in oncology",

abstract = "An estimated 38,890 Americans will be diagnosed with kidney cancer and 12,840 will die of this disease in the United States in 2006. Renal cell carcinoma (RCC) constitutes approximately 2% of all malignancies, with a median age at diagnosis of 65 years. Smoking and obesity are among the risk factors for RCC development, and tumor grade, local extent of the tumor, presence of regional nodal metastases, and evidence of metastatic disease at presentation are the most important prognostic determinants of 5-year survival. These guidelines discuss evaluation, staging, treatment, and management after treatment.",

keywords = "Clear cell tumors, Kidney disease, NCCN Clinical Practice Guidelines, Nephrectomy, Renal cell carcinoma",

author = "Motzer, {Robert J.} and Bolger, {Graeme B.} and Barry Boston and Carducci, {Michael A.} and Mayer Fishman and Hancock, {Steven L.} and Hauke, {Ralph J.} and Hudes, {Gary R.} and Eric Jonasch and Philip Kantoff and Kuzel, {Timothy M.} and Lange, {Paul H.} and Levine, {Ellis G.} and Chris Logothetis and Margolin, {Kim A.} and Kamal Pohar and Redman, {Bruce G.} and Robertson, {Cary N.} and Samlowski, {Wolfram E.} and Joel Sheinfeld",

year = "2006",

month = nov,

doi = "10.6004/jnccn.2006.0089",

language = "English (US)",

volume = "4",

pages = "1072--1081",

journal = "JNCCN Journal of the National Comprehensive Cancer Network",

issn = "1540-1405",

publisher = "Cold Spring Publishing LLC",

number = "10",

}

Motzer, RJ, Bolger, GB, Boston, B, Carducci, MA, Fishman, M, Hancock, SL, Hauke, RJ, Hudes, GR, Jonasch, E, Kantoff, P, Kuzel, TM, Lange, PH, Levine, EG, Logothetis, C, Margolin, KA, Pohar, K, Redman, BG, Robertson, CN, Samlowski, WE & Sheinfeld, J 2006, 'Kidney cancer clinical practice guidelines in oncology', JNCCN Journal of the National Comprehensive Cancer Network, vol. 4, no. 10, pp. 1072-1081. https://doi.org/10.6004/jnccn.2006.0089

TY - JOUR

T1 - Kidney cancer clinical practice guidelines in oncology

AU - Motzer, Robert J.

AU - Bolger, Graeme B.

AU - Boston, Barry

AU - Carducci, Michael A.

AU - Fishman, Mayer

AU - Hancock, Steven L.

AU - Hauke, Ralph J.

AU - Hudes, Gary R.

AU - Jonasch, Eric

AU - Kantoff, Philip

AU - Kuzel, Timothy M.

AU - Lange, Paul H.

AU - Levine, Ellis G.

AU - Logothetis, Chris

AU - Margolin, Kim A.

AU - Pohar, Kamal

AU - Redman, Bruce G.

AU - Robertson, Cary N.

AU - Samlowski, Wolfram E.

AU - Sheinfeld, Joel

PY - 2006/11

Y1 - 2006/11

N2 - An estimated 38,890 Americans will be diagnosed with kidney cancer and 12,840 will die of this disease in the United States in 2006. Renal cell carcinoma (RCC) constitutes approximately 2% of all malignancies, with a median age at diagnosis of 65 years. Smoking and obesity are among the risk factors for RCC development, and tumor grade, local extent of the tumor, presence of regional nodal metastases, and evidence of metastatic disease at presentation are the most important prognostic determinants of 5-year survival. These guidelines discuss evaluation, staging, treatment, and management after treatment.

AB - An estimated 38,890 Americans will be diagnosed with kidney cancer and 12,840 will die of this disease in the United States in 2006. Renal cell carcinoma (RCC) constitutes approximately 2% of all malignancies, with a median age at diagnosis of 65 years. Smoking and obesity are among the risk factors for RCC development, and tumor grade, local extent of the tumor, presence of regional nodal metastases, and evidence of metastatic disease at presentation are the most important prognostic determinants of 5-year survival. These guidelines discuss evaluation, staging, treatment, and management after treatment.

KW - Clear cell tumors

KW - Kidney disease

KW - NCCN Clinical Practice Guidelines

KW - Nephrectomy

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=33751558602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33751558602&partnerID=8YFLogxK

U2 - 10.6004/jnccn.2006.0089

DO - 10.6004/jnccn.2006.0089

M3 - Article

C2 - 17112454

AN - SCOPUS:33751558602

SN - 1540-1405

VL - 4

SP - 1072

EP - 1081

JO - JNCCN Journal of the National Comprehensive Cancer Network

JF - JNCCN Journal of the National Comprehensive Cancer Network

IS - 10

ER -

Kidney cancer clinical practice guidelines in oncology

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this